Eli Lilly & Co. (LLY) Tops Q3 EPS by 7c; Offers FY22 EPS Guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,152.93 --0%
Revenue Growth %: +26.0%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +26.0%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.98, $0.07 better than the analyst estimate of $1.91. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.91 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $7.70-$7.85, versus the consensus of $7.99.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly (LLY) PT Raised to $1,284 at Guggenheim
- Arrive AI and DXC Technology partner to bring delivery tech to factories
- Raymond James Reiterates Outperform Rating on Progressive Corp. (PGR)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
